Immunoglobulin preparations for intravenous or subcutaneous administration are the cornerstone of treatment in patients with primary immunodeficiency diseases affecting the humoral immune system. This is an update of the evidence-based guidelines on immunoglobulin therapy, last published in 2006.
Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol. March 2017, Volume 139, Issue 3, Supplement, Pages S1–S46